A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial.

Francesca SimionatoCamilla ZecchettoValeria MerzAlessandro CavaliereSimona CasalinoMarina GauleMirko D'OnofrioGiuseppe MalleoLuca LandoniAlessandro EspositoGiovanni MarchegianiLuca CasettiMassimiliano TuveriSalvatore PaiellaFilippo ScopellitiAlessandro GiardinoIsabella FrigerioPaolo RegiPaola CapelliStefano GobboArmando GabbrielliLaura BernardoniVita FedeleIrene RossiCristiana PiazzolaSerena GiacomazziMartina PasquatoMorena GianfortoneStefano MilleriMichele MilellaGiovanni ButturiniRoberto SalviaClaudio BassiDavide Melisi

Published in: Therapeutic advances in medical oncology (2020)

Clinicaltrial.gov: NCT03528785. Trial registration data: 1 January 2018Protocol number: CRC 2017_01EudraCT Number: 2017-000345-46.

Keyphrases

phase ii study
phase iii
open label
locally advanced
study protocol
phase ii
clinical trial
randomized controlled trial
electronic health record
rectal cancer
big data
radiation therapy
deep learning